Mr. R., 64, arrives with an anterior STEMI and is already in shock: systolic pressure in the 80s on norepinephrine, lactate rising, ejection fraction about 25% on echo. He is awake and following commands. His culprit artery has been opened, and he is now in the cardiac ICU; he still needs a vasopressor, and the order set offers both norepinephrine and dopamine. The shock course follows him from the cath lab to the ICU; each trial answers one decision in his care.
This page helps you decide: Mr. R. needs a vasopressor. Norepinephrine or dopamine?
After this page you can
Work through the six steps in order. Each question at the end belongs to one step, and the answer is on that step's page.
For Mr. R., a patient in cardiogenic shock who needs a vasopressor, keep norepinephrine rather than switching to dopamine: SOAP II showed no survival gain with dopamine, about one extra arrhythmic event for every 9 patients, and more deaths in its cardiogenic-shock subgroup, a signal rather than proof. On the one-pager it sits on page 2, in the “Vasoactive drugs — lowest dose, shortest time” table (Norepinephrine and Dopamine rows).